Evidence map›Paper›PMID 42321236›Full record

ArticleNPJ Parkinson's disease2026

Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α-synuclein rat model of Parkinson's disease.

Hanna Weber, Meike Statz, Nicolas Casadei, Olaf Riess, Franziska Richter, Wiebke Hermann, Alexander Storch, Mareike Fauser

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hanna WeberDepartment of Neurology, University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany. hanna.weber@med.uni-rostock.de.
Meike StatzDepartment of Neurology, University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.
Nicolas CasadeiInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076, Tübingen, Germany.
Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076, Tübingen, Germany.
Franziska RichterCenter for Systems Neuroscience Hannover (ZSN), 30559, Hannover, Germany.
Wiebke HermannDepartment of Neurology, University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.
Alexander StorchDepartment of Neurology, University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.
Mareike FauserDepartment of Neurology, University Medical Center Rostock, University of Rostock, 18147, Rostock, Germany.

Funding

Deutsche Forschungsgemeinschaft SFB 1270/2-299150580
6 · The paper itself

Abstract

Disruption of circadian rhythms is a key feature of neurodegenerative diseases and a non-motor feature of Parkinson's disease, which significantly impairs health-related quality of life; yet, the underlying mechanisms are only partially understood. Preclinical animal models with neuropathological and symptomatic significance might contribute to a better understanding of circadian dysfunction. Here, we investigated light-dark phase-dependent modulation of motor and non-motor behavior as well as suprachiasmatic nucleus integrity in α-synuclein-overexpressing rats and wild-type controls. Behavioral testing in 3-month-old animals revealed robust phase-dependent modulation of exploratory activity, locomotion, sucrose preference, and olfaction-guided feeding in wild-type rats, which was absent in their transgenic littermates. Histological analyses demonstrated reduced overall cell density and pronounced α-synuclein accumulation in the suprachiasmatic nucleus of α-synuclein rats, accompanied by altered cellular composition, including altered neuronal, orexinergic, and microglial markers. α-synuclein load was positively correlated with Orexin A

Identifiers

PMID42321236
PMCPMC13282383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.